Cytokine Signalling Forum
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
- Autore: Vários
- Narratore: Vários
- Editore: Podcast
- Durata: 0:20:16
- Altre informazioni
Informações:
Trama
Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib and adalimumab in cases of insufficient response.
